Tag Archives: Patients

Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease

Print this page June 1, 2020 — AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most common type of heart disease. The approval by the US Food and Drug Administration (FDA) was based on… Read More »

Coronavirus: GPs not told when patients removed from ‘shielding lists’

Some extremely vulnerable people have been removed from shielding lists via text message, without the knowledge of their GP. This has caused confusion, with charities demanding clearer guidance for this group as lockdown eases. GPs say they should be notified when their patients are added or removed from the lists. Shielding has now been extended… Read More »

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas Print this page 13 April 2020 — AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved the kinase inhibitor Koselugo… Read More »

New York ICU nurse sobs after ‘walking into rooms and your patients are dead’ from coronavirus

D’neil Schmall (Credit: screenshot) In a heartbreaking video making its rounds on social media, an ICU nurse working on the frontlines of the COVID-19 pandemic lost her composure and broke down in tears while recalling what it’s been like to see so many of her patients die under her care. At the end of March,… Read More »

Hospital costs to treat uninsured COVID-19 patients could top $40B

Dive Brief: The Trump administration’s plan to use the $ 100 billion in emergency COVID-19 funding approved March 27 to pay hospitals for treating the uninsured could take up as much as 40% of that funding, according to an analysis released Tuesday by the Kaiser Family Foundation. Treating the uninsured for symptoms of the disease… Read More »